Leukocyte phenotype changes induced by specific immunotherapy in patients with birch allergy

Journal of Investigational Allergology and Clinical Immunology

Volumn 20, Issue 6, 2010, Pages 476-483

  Mansson A ^a   Bachar, O ^a   Adner, M ^b   Bjornsson S ^a   Cardell, L O ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergic rhinitis; Flow cytometry; IgE; Regulatory T cells; Specific immunotherapy

Indexed keywords

ALUTARD; ANTIBODY; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CD11B ANTIGEN; CD69 ANTIGEN; CD98 ANTIGEN; CORTICOSTEROID; EYE DROPS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR;

ADULT; ALLERGEN SPECIFIC IMMUNOTHERAPY; ARTICLE; BIRCH; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; DRUG TARGETING; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HAY FEVER; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LEUKOCYTE; MALE; MONOCYTE; NEUTROPHIL; PHENOTYPE; POLLEN ALLERGY; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADULT; ANTIGENS, CD11B; BETULA; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOPHENOTYPING; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, IGG; T-LYMPHOCYTES;

EID: 78650151284     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. James LK, Durham SR. Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy. 2008;38(7):1074-1088.
2. Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol. 2004;113(6):1025-1034; quiz 1035.
3. Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 2006;6(10):76171.
4. Frew AJ. 25. Immunotherapy of allergic disease. J Allergy Clin Immunol. 2003;111(2 Suppl):S712-S719.
5. Ebner C. Immunological mechanisms operative in allergen-specific immunotherapy. Int Arch Allergy Immunol. 1999;119(1):1-5.
6. Cevit O, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB. Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children. J Investig Allergol Clin Immunol. 2007;17(5):286-291.
7. + T cells by grass pollen immunotherapy. J Allergy Clin Immunol. 2003;111(6):1255-1261.
8. Plewako H, Wosinska K, Arvidsson M, Bjorkander J, Skov PS, Hakansson L, Rak S. Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy. Int Arch Allergy Immunol. 2006;141(4):346-353.
9. Burg ND, Pillinger MH. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol. 2001;99(1):7-17.
10. Dorfman DM, Shahsafaei A. CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas. Hum Pathol. 2002;33(3):330-334.
11. Miyamoto YJ, Mitchell JS, McIntyre BW. Physical association and functional interaction between beta1 integrin and CD98 on human T lymphocytes. Mol Immunol. 2003;39(12):739-751.
12. Diaz LA, Jr., Friedman AW, He X, Kuick RD, Hanash SM, Fox DA. Monocyte-dependent regulation of T lymphocyte activation through CD98. Int Immunol. 1997;9(9):1221-1231.
13. Nguyen XD, Eichler H, Dugrillon A, Piechaczek C, Braun M, Kluter H. Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. J Immunol Methods. 2003;275(1-2):57-68.
14. Chang J, Hong CS. The effect of immunotherapy on nonspecific bronchial hyperresponsiveness in bronchial asthma and allergic rhinitis. Yonsei Med J. 2001;42(1):106-113.
15. Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AK, Hill BM. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest. 1973;52(2):472-482.
16. Gleich GJ, Zimmermann EM, Henderson LL, Yunginger JW. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J Allergy Clin Immunol. 1982;70(4):261-271.
17. Ito H, Suzuki M, Mamiya S, Takagi I, Baba S. Study on changes in the level of serum IL-4 and soluble CD 23(s-CD23) with immunotherapy in nasal allergy patients. Acta Otolaryngol Suppl. 1996;525:98-104.
18. + B lymphocytes and clinical outcome in asthmatic patients receiving specific rush immunotherapy. Int Arch Allergy Immunol. 1996;111(2):188-194.
19. Kinhult J, Egesten A, Benson M, Uddman R, Cardell LO. Increased expression of surface activation markers on neutrophils following migration into the nasal lumen. Clin Exp Allergy. 2003;33(8):1141-1146.
20. Fransson M, Benson M, Wennergren G, Cardell LO. A role for neutrophils in intermittent allergic rhinitis. Acta Otolaryngol. 2004;124(5):616-620.
21. Woodruff PG, Fahy J V. A role for neutrophils in asthma? Am J Med. 2002;112(6):498-500.
22. Grage-Griebenow E, Flad HD, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol. 2001;69(1):11-20.
23. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood. 1996;87(1):373-377.
24. Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, Pryjma J. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol. 2008;67(2):152-159.
25. Royer B, Varadaradjalou S, Saas P, Guillosson JJ, Kantelip J P, Arock M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy. 2001;31(5):694-704.
26. Takanaski S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med. 1994;180(2):711-715.
27. + monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun. 1998;66(6):2782-2790.
28. Emminger W, Zlabinger GJ, Fritsch G, Urbanek R. CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis. Eur J Immunol. 2001;31(6):1716-1719.
29. Novak N, Allam P, Geiger E, Bieber T. Characterization of monocyte subtypes in the allergic form of atopic eczema/ dermatitis syndrome. Allergy. 2002;57(10):931-935.
30. Ziegler S F, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells 1994;12(5):456-465.
31. Zola H. Markers of cell lineage, differentiation and activation. J Biol Regul Homeost Agents. 2000;14(3):218-219.
32. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 2003;33(5):1205-1214.
33. Jayasekera N P, Toma T P, Williams A, Rajakulasingam K. Mechanisms of immunotherapy in allergic rhinitis. Biomed Pharmacother. 2007;61(1):29-33.
34. Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol. 2008;121(6):1467-72, 1472 e1461.
35. Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol. 2008;121(5):1120-1125 e1122.
36. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, Carr VA, Robinson DS. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 2004;363(9409):608-615.
37. Stock P, DeKruyff RH, Umetsu DT. Inhibition of the allergic response by regulatory T cells. Curr Opin Allergy Clin Immunol. 2006;6(1):12-16.
38. +) regulatory T cells during pollen season. J Clin Immunol. 2009;(6):752-760.